dc.contributor.author | Organización Mundial de la Salud | es |
dc.coverage.spatial | Ginebra | |
dc.date.accessioned | 2012-06-17T00:31:41Z | |
dc.date.available | 2012-06-17T00:31:41Z | |
dc.date.created | 2000 | es |
dc.date.issued | 2000 | es |
dc.identifier.govdoc | WHO/EDM/2000.4 | es |
dc.identifier.uri | https://iris.who.int/handle/10665/66775 | |
dc.description | WHO/EDM/2000.4 | es |
dc.description | 6 p. | es |
dc.language.iso | en | en |
dc.language.iso | fr | en |
dc.language.iso | es | en |
dc.publisher | Organización Mundial de la Salud | es |
dc.relation.ispartofseries | Perspectivas políticas sobre medicamentos de la OMS ; no.1 | es |
dc.subject.mesh | Drug and Narcotic Control | es |
dc.subject.mesh | Drug Utilization | es |
dc.subject.mesh | World Health Organization | es |
dc.subject.mesh | Drugs, Essential | |
dc.subject.other | Pharmaceuticals and Biologicals | es |
dc.title | Estrategia sobre medicamentos de la OMS : 2000-2003 | es |
dc.subject.meshqualifier | supply and distribution | es |
dc.subject.meshqualifier | standards | es |
who.relation.languageVersion | 10665/66722 | en |
who.relation.languageVersion | 10665/66694 | en |